 |
인쇄하기
취소
|
Pharmaceutical firms see operating profit plunge in 2011
Most of Korea's drug makers saw their earnings fall last year amid dramatic changes in the business environment such as regulations by the government and intense competition among generic drugs, data showed Monday.
The combined sales of 110 drug firms (55 listed firms and 50 unlisted firm on Seoul bourse) posted 12.9 trillion won in sales and 1.1 trillion won in operating profit (OP) last ye...
The combined sales of 110 drug firms (55 listed firms and 50 unlisted firm on Seoul bourse) posted 12.9 trillion won in sales and 1.1 trillion won in operating profit (OP) last ye...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.